Patricia K. Coyle, MD

Articles

Ofatumumab and the Anti-CD20 Class

October 26, 2021

An expert discusses takeaways about the anti-CD20 monoclonal antibody class of disease-modifying therapies for patients with relapsing multiple sclerosis through the lens of ofatumumab (Kesimpta; Novartis).

Managing Multiple Sclerosis in the Community Setting

June 21, 2021

Advice to community physicians and neurologists who play a role in caring for patients with multiple sclerosis in community practices on optimizing therapy with high-efficacy and newer treatment options.

Impressions of a 25-Year-Old Woman With Relapsing MS

May 24, 2021

Clyde E. Markowitz, MD, reacts to how he would manage a 25-year-old woman who presents with 2 weeks of progressive left-sided monocular vision loss and pain with eye movement, but reports no other symptoms or significant history.